When did Medifast report Q2 2025 earnings?

Medifast (MED) reported Q2 2025 earnings on August 4, 2025 after market close.

What were Medifast's Q2 2025 revenue and EPS?

Medifast reported revenue of $105.6M and eps of $0.04 for Q2 2025.

Did Medifast beat estimates in Q2 2025?

Revenue beat the consensus estimate of $93.8M by $11.8M. EPS beat the consensus estimate of $-0.30 by $0.34.

How did Medifast's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 37.4% from $168.6M a year earlier and eps declined 95.7% from $0.92.

Where can I find Medifast's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0000910329-25-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.

Medifast MED Q2 2025 earnings

Reported August 4, 2025 · After market close

Revenue$105.6MBeat by $11.8M

EPS$0.04Beat by $0.34

Revenue estimate$93.8M

EPS estimate-$0.30

Next report

Aug 3, 2026 (Today)

Revenue estimate$72.7M

EPS estimate-$0.65

Financials

Q2 2025

Income statement

See full

Revenue$105.6M-37.4%

Gross profit$76.6M-37.9%

Operating income-$1.1M+86.5%

Net income$2.5M+130%

EPS (diluted)$0.22+129%

Balance sheet

See full

Cash & equivalents$101.7M-5.9%

Total debt$13.1M-31.6%

Total equity$216.0M+5.2%

Total assets$269.3M-8.2%

Cash flow

See full

CapEx$1.4M-28.9%

Free cash flow-$4.8M-143%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$150.58M-36.9%

Enterprise value$61.95M-58.6%

P/E41.4×+33.3×

P/S0.3×0.0×

Profitability

See full

Gross margin73.8%-0.1pp

Operating margin0.1%-4.3pp

Net margin0.8%-3.1pp

Returns & leverage

See full

Return on equity1.7%-13.3pp

Debt / equity0.1×0.0×

Current ratio4.5×+1.5×

Segments

By segment

See full

Optavia Segment$105.6M-37.4%

Versus estimates

Revenue

Q1 2026$76.0MBeat by $6.8M Q4 2025$75.1MBeat by $3.7M Q3 2025$89.4MBeat by $18.0M

Q2 2025$105.6MBeat by $11.8M

Q1 2025$115.7MBeat by $19.6M Q4 2024$119.0MBeat by $4.8M

Diluted EPS

Q1 2026-$0.19Beat by $0.36 Q4 2025-$0.55Beat by $0.21 Q3 2025-$0.21Miss by $0.20

Q2 2025$0.04Beat by $0.34

Q1 2025-$0.11Miss by $0.04 Q4 2024$0.10Beat by $0.26

Ask the moment Medifast reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Medifast report Q2 2025 earnings?: Medifast (MED) reported Q2 2025 earnings on August 4, 2025 after market close.
What were Medifast's Q2 2025 revenue and EPS?: Medifast reported revenue of $105.6M and eps of $0.04 for Q2 2025.
Did Medifast beat estimates in Q2 2025?: Revenue beat the consensus estimate of $93.8M by $11.8M. EPS beat the consensus estimate of $-0.30 by $0.34.
How did Medifast's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 37.4% from $168.6M a year earlier and eps declined 95.7% from $0.92.
Where can I find Medifast's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0000910329-25-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.